butabarbital will decrease the level or result of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Effect of coadministering a strong CYP3A4 inducer with fedratinib hasn't been studied. butabarbital will lower the extent or outcome of aprepitan